交通2
泛素连接酶
细胞生物学
凋亡抑制因子
夏普
泛素
信号转导
IκB激酶
生物
NF-κB
肿瘤坏死因子α
死亡域
癌症研究
细胞凋亡
程序性细胞死亡
肿瘤坏死因子受体
免疫学
半胱氨酸蛋白酶
生物化学
基因
标识
DOI:10.1007/978-1-4419-6612-4_7
摘要
When first identified in the mid-1990s, cellular inhibitor of apoptosis (c-IAP1 and c-IAP2) proteins and tumor necrosis factor receptor-associated factor 2 (TRAF2) were described as putative mediators of TNFR2 signaling. The following years witnessed an immense number of studies confirming the seminal role of both cellular IAPs and of TRAF2 in transducing signaling initiated by TNF family ligands. As such, c-IAP1 and c-IAP2 suppress TNF-stimulated cell death by preventing the formation of the TNF receptor 1 (TNFR1) pro-apoptotic signaling complex. In combination with their obligatory binding partner, TRAF2, c-IAP proteins regulate pro-survival nuclear factor-kappaB (NF-κB) signaling pathways. In the TNFα-induced canonical NF-κB pathway, c-IAP1 and 2 are required for receptor interacting protein 1 (RIP1) ubiquitination and NF-κB activation. In the noncanonical NF-κB pathway, c-IAP1 and 2 ubiquitinate NF-κB-inducing kinase (NIK), leading to its proteasomal degradation and abrogation of NF-κB signaling. In addition, through the RING domain mediated ubiquitin ligase activity, c-IAP proteins regulate their own stability and the protein levels of several of their binding partners including TRAF2. Here I discuss the most recent progress in our understanding of the biological roles of c-IAPs and TRAF2, as well as the implications of targeting these molecules for therapeutic interventions.
科研通智能强力驱动
Strongly Powered by AbleSci AI